Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Biocytogen Pharmaceuticals (Beijing), a clinical-stage biotechnology company with a focus on the antibody discovery and […]
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
Merck, known as MSD outside of the United States and Canada, and Kelun-Biotech, a clinical-stage […]
HealthTech Arkansas and Laina Enterprises Partner to Provide Clinical Trial Software to the BioAR Trial Accelerator Participants
HealthTech Arkansas and Laina Enterprises have partnered to provide support to the biotherapeutics startup companies […]
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Kite and Tmunity Therapeutics have announced that the companies have signed an agreement in which […]
XtalPi and EDDC Collaborate in AI-empowered Drug Discovery Program for Non-Small Cell Lung Cancer
XtalPi, a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, has announced […]
CenSyn and HonorHealth Announce Strategic Partnership
CenSyn, a digital telehealth company advancing portable screening of brain health-related conditions via its platform […]
PhoreMost and ThinkCyte Collaborate to Advance AI Based Drug Discovery
PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, […]
Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases
Sosei Group Corporation announces it has entered a drug discovery collaboration with Eli Lilly and […]
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) […]
Theolytics Starts a £1m Project in Collaboration With the University of Sheffield, Supported by Innovate UK to Develop a Novel Therapy for Multiple Myeloma Patients
Theolytics is a biotechnology company harnessing viruses to combat disease. The company has been awarded […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more